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Vitamin D level in preschool children with recurrent wheezy chest, and its relation to 
the severity of the wheezing episodes 
 
INTRODUCTION 
Recurrent wheezy chest is one of the chronic 
childhood disorders1.The prevalence of wheezy 
chest ranges from 1 to 18 % in different countries2. 
Worldwide, the prevalence is increasing especially 
among the preschool children3. It represents a 
common cause of Pediatric Emergency department 
admission, with more sleep disturbance, more 
limitation to the daily activities and more healthcare 
expenditure4. 
The term "recurrent wheezy chest" is preferable 
to the term asthma in preschool children as 
demonstration of airflow limitation and reliable 
pulmonary function testing cannot be done in this 
age group3. However, the last edition of the Global 
Initiative for Asthma (GINA), still used to describe 
recurrent wheezy chest in children younger than 5 
years as asthma5. 
 
Identification of recurrent wheezy preschool 
children who are at risk for persistent asthma has 
mainly focused on simple clinical and laboratory 
parameters. The Asthma Predictive Index6 (API) 
has become the most used tool to predict persistent 
asthma beyond the age of 6 years. It is an index 
based on the presence of  ≥3 wheezy episodes per 
year and one major criteria (physician diagnosed 
parental asthma and/or eczema) or two minor 
criteria (physician diagnosed allergic rhinitis, 
wheezing apart from colds and peripheral 
eosinophilia ≥4 %). A modified API was introduced 
in 2004.7 This index differs from the original API 
because it requires ≥4 wheezing episodes with at 
least one diagnosed by a physician, whereas allergic 
rhinitis is replaced by sensitization to aeroallergens 
(major criterion) and allergic sensitivity to milk, 
eggs or peanuts (minor criterion). 
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Vitamin D has new emerging protective roles in 
extra-skeletal disorders, as inflammatory, allergic, 
infectious and autoimmune disorders8. Vitamin D 
has a significant role as an immunomodulator of the 
innate and adaptive immune systems. Nearly every 
immune cell express vitamin D receptors and 1α-
hydroxylase, both are the key regulators for vitamin 
D action9. Worldwide, vitamin D insufficiency is 
still a growing problem, even in countries where 
there is abundance of sunshine that could help 
vitamin D synthesis all over the year10. There is a 
limited data about the prevalence of vitamin D 
deficiency and its relationship with wheezy chest in 
the preschool age group in our community. 
It has been claimed that vitamin D deficiency 
and insufficiency may be linked to poor function of 
the lung, more severe wheezing episodes, and more 
emergency department visits in young children with 
recurrent wheezy chest11. On the other hand, 
conflicting findings have been reported from other 
studies, that denied any relationship between 
vitamin D status and asthma12,13.  
 
METHODS 
Study design and patients  
This cross-sectional study was conducted on 100 
consecutive preschool children with recurrent 
wheezy chest, attending the Emergency 
Department, Allergy and Pulmonology units at 
Assiut University Children’s Hospital, in Egypt, in 
the period from Dec 2014 to May 2016. The study 
was approved by the institutional ethical committee 
of Assiut University Faculty of Medicine, Egypt. 
The study was funded by Faculty of Medicine, 
Assiut University. An informed consent was 
obtained from the parents of the patients before 
their recruitment in the study.  
The inclusion criteria were: children of both 
sexes, aged 2 to 5 years, fulfilling the GINA criteria 
of asthma diagnosis in children 5 years and younger 
which is 3 or more documented episodes of wheeze, 
cough, and difficulty breathing in the year 
preceding the study with clinical improvement on 
inhaled short-acting beta 2-agonist5. Children on 
vitamin D supplements in the last three months, 
those with manifestations of rickets, pneumonia or 
chronic respiratory diseases, and children with any 
chronic CNS, hepatic, metabolic, or renal diseases 
were excluded from the study. 
Methodology  
All patients enrolled in this study were subjected to 
complete medical history taking, comprehensive 
physical examination, chest X-ray, and laboratory 
investigations. 
Phase I International Study of Asthma and Allergies 
in Childhood (ISAAC) questionnaire14 was used, it 
included: 
• Age, sex, the season of birth, residence, mode of 
delivery, and socioeconomic position according to 
the modified classification of socioeconomic 
position in Egypt15. 
• Description of the wheezy episodes in the last 
year, whether it is episodic (episodes at a specific 
time periods, more with infections, with free 
intervals in between the episodes) or multiple 
trigger wheeze (episodes with persistent 
symptoms in between, as during sleep or exercise, 
laughing, crying or exposure to cold air or 
smoke)16, and emergency department visits, and 
the number of in-hospital stays for every patient.  
The Pediatric Respiratory Assessment Measure 
(PRAM score), that can be used for assessment of 
asthma severity in children aged 2-17 years was 
applied. This 12-point score includes oxygen 
saturation (0-2), suprasternal retraction (0-2), 
scalene muscle contraction (0-2), air entry (0-3), 
and wheeze (0-3). Accordingly, the patients with 
the wheezing episodes were classified into mild 
episodes (score 1-3), moderate episodes (score 4-7), 
severe episodes (score 8-12)5,17. 
Assessment of level of asthma control in 
children ≤5 years, was done by asking the parents 4 
questions regarding the daytime and nighttime 
symptoms, activity limitation and the use of inhaled 
bronchodilator more than once a week. Patients 
were grouped as well controlled (no question was 
answered by yes), partially controlled (1-2 
questions were answered by yes) or uncontrolled 
(3-4 questions were answered by yes)5. 
Laboratory investigation: 
▪ Laboratory investigations were performed in the 
laboratories of Assiut University Hospitals. 
▪ Collection of blood samples: venous blood (5 ml) 
sample was collected from each patient under 
aseptic precautions into an EDTA tube (2 ml; for 
complete blood count) and into a plain 
Wassermann’s tube (3 ml). Plain tubes were 
placed in water bath (37°C) for 15 minutes and 
sera were separated by centrifugation at 3000 rpm 
for 15 minutes. Grossly haemolysed or lipaemic 
sera were rejected and new samples were 
collected. 
▪ Complete blood count, with special attention to 
eosinophil count, was done on Celltac Es (MEK-
7300, Nihon Kohden, Japan) and peripheral blood 
smear was prepared and stained by Leishman’s 
stain18. 
▪ Serum total IgE level was measured using 
VIDAS Total IgE test kits (Cat. no. 30419, 
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BioMérieux S.A., France) according to 
manufacturer’s instructions. VIDAS Total IgE 
assay is an automated quantitative test using the 
Enzyme-Linked Fluorescent Assay (ELFA) 
technique which combines an enzyme 
immunoassay sandwich method with a final 
fluorescent detection. The reference range 
recommended by the manufacturer is up to 46 
KIU/L in children below 3 years and up to 280 
KIU/L in children from 3-16 years old. 
▪ Serum Vitamin D (25-OH-D) level was 
measured using 25-OH Vitamin D3/D2 test strips 
(cat. no. ORG 270, ORGENTEC Diagnostika 
GmbH, Germany) on Alegria Random Access 
Analyser (ORGENTEC Diagnostika GmbH, 
Germany) according to manufacturer’s 
instructions. The Alegria® Random Access 
Analyser is an enzyme linked immunosorbent 
assay (ELISA) based test system. The 
Measurement range of this Alegria assay is 5 - 
200 ng/ml. 
Reference range of serum (OH) vitamin D levels 
were as follow19  
Deficient: (< 20 ng/ml), 
Insufficient: (≥ 20ng/ml - < 30ng/ml) and 
Sufficient: (≥ 30ng/ml) 
The studied patients were grouped into 2 groups: 
sufficient group when 25(OH) vitamin D level is ≥ 
30 ng/mL and below-sufficient when 25(OH) 
vitamin D level is <30 ng/mL (including patients 
with deficient and insufficient 25(OH) vitamin D 
level). 
 
Statistical analysis  
Data entry and statistical analysis were done into 
SPSS version 19 (Statistical Package for Social 
Sciences). The quantitative data was presented as 
mean ± SD, median and interquartile range (IQR). 
For comparison, the Student’s t-test and ANOVA 
were used in the normally distributed data and 
Mann-Whitney U-test and Kruskal-Wallis test were 
used with data not normally distributed.  
The qualitative data was presented as number 
and percentage. For comparison, Chi-square (X²) 
test was used and Fisher’s exact test was used 
instead when the expected frequency is less than 5. 
Pearson and Spearman correlation tests were used 
for correlation. For all tests, a probability value (p 




Tables 1 and 2 show the clinico-demographic and 
laboratory characteristics of the enrolled patients. 
Table 3 shows the variation of the clinical and 
laboratory parameters of the enrolled patients 
according to their PRAM score. Vitamin D levels 
were significantly lower among patients with severe 
episodes. Furthermore, the PRAM score was 
significantly lower in the Vitamin D sufficient 
group in comparison to the below-sufficient group 
(p=0.025) (Table 4). There was a negative 
significant correlation between PRAM score and 
25(OH) vitamin D level (r = -0.334, p = 0.001) 
(Figure 1). 
 
Figure 1. Correlation between 25(OH) Vitamin D level and PRAM score. 
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Table 1. Demographic and clinical characteristics of enrolled patients. 
Item n (%), Mean ± SD 
or Median (IQR)  
Age (years) 
2 - < 3 
 
35(35.0) 
3 - < 4 36(36.0) 
4 - ≤ 5 29(29.0) 
Mean ± SD  3.20 ± 0.84  
Median (IQR) 3.0(2.4-4.0) 














Medium  26(26.0) 
High 4(4.0) 




Multiple trigger wheeze 47(47.0) 
Number of wheezy episodes in the last year  Median (IQR) 6 (4-9) 
Number of patients admitted to the hospital by the wheezy episode  in the last year 47 (47.0) 
Number of hospital admission in last year (per patient)   Median (IQR) 6(2 - 8) 
Duration of in-hospital stay(days) Mean ± SD 2.91 ± 0.43 
Median (IQR) 3(2-4) 




Moderate episode 49(49.0) 
Severe episode   44(44.0) 




Partially controlled  49 (49.0) 
Controlled  1 (1.0) 
IQR: Interquartile Range, n:number (n=100), PRAM: Pediatric Respiratory Assessment Measure, SD: Standard Deviation.  
 
Table 2. Laboratory data of the enrolled patients. 
Item n (%), Mean ± SD or 
Median (IQR) 
Total leukocytic count (cells/µ L )   
Mean ± SD  
 
9470 ± 4350 
Median (IQR) 8600(6125 - 11350) 
Absolute Eosinophil count (cells/ µ L) 
Mean ± SD  
 
392.21 ± 465.57 
Median (IQR) 250(76.25 - 458.25) 
Patients with Eosinophilia ≥ 4 %  41(41.0) 
Serum IgE level (kIU/L)         
Mean ± SD  
 
476.56 ± 933.26 
Median (IQR) 122.2 (48.31- 428.55) 
Patients with elevated serum IgE level, n (%) 
< 3 years 
50(50.0) 
26(26.0) 
 3 - ≤ 5 years 24(24.0) 
Serum 25(OH) Vitamin D (ng/ml) 
Mean ± SD 
 
32.97 ± 22.81 
Median (Range) 27.7 (17.65- 42) 
Serum 25(OH) Vitamin D category, n (%)  




Including: Deficient(< 20 ng/ml) 32/53 
                 Insufficient(≥ 20ng/ml - <30ng/ml) 21/53 
kIU/L: International kilo-units per liter, IQR: Interquartile Range, µL: microliter, ml: milliliter, ng: nano gram, SD: Standard Deviation. 
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Age Median (IQR) 2.5(2-4.5) 3(2.5-3.8) 3(2.6-4.23) 0.463 1.53 




















30 (68.2%) 0.166 
 
3.594 
Urban 0 (0%) 11 (22.4%) 14 (31.8%) 












4.824 Medium 4 (57.1%) 11 (22.4%) 11 (25.0%) 
High 0 (0.0%) 3 (6.1%) 1 (2.3%) 




























































kIU/L: International kilo-units per liter, IQR: Interquartile Range, µ L: microliter, ml: milliliter, n:number (n=100), ng: nano gram, SD: 
standard deviation. 
*Significant.  Chi-square, Kruskal Wallis, Mann Whitney tests were used to estimate p value. 
$ Significant difference between mild and moderate groups (p=0.034) and between mild and severe groups (p=0.009).  
$$ Significant difference between the moderate and severe groups (p=0.007).  
 
Table 4. Comparison of the characteristics of the enrolled patients according to 25 (OH) Vitamin D level. 
 25(OH) Vitamin D level 
Item 
Below-sufficient  
(< 30ng/ml) n=53 
Sufficient  
(≥ 30ng/ml) n=47 
Test value p-value 
Age Median (IQR) 3(2.5-4) 3(2.5-4) 0.150 0.881 








Female 17 (32.1%) 15 (31.9%) 










 Urban 14 (26.4%) 11 (23.4%) 













Medium 8 (15.1%) 18 (38.3%) 
High 1 (1.9%) 3 (6.4%) 
Number of the wheezy episodes in last year   









PRAM score Median (IQR) 8(6.5-9) 7(5-8) 2.240 0.025* 










Partially controlled 22 (41.5%) 27 (57.4%) 2.53 0.112 
Uncontrolled  31 (58.5%) 19 (40.4%) 3.25 0.071 
Total leukocytic count (cells/µL) Median (IQR) 9.9 (6.45-12.9) 7.5 (6-10.1) 1.969 0.049* 
Absolute Eosinophil count (cell/µL) Median (IQR)  260.4 (82.5-480) 216.2(66-450) 0.366 0.714 
Serum IgE level (kIU/L) Median (IQR) 108.5 (42.92-326.9) 132.5 (54-588.3) 0.798 0.425  
kIU/L: international kilo-units per liter, IQR: Interquartile Range, µ L: microliter, ml: milliliter, n:number (n=100), ng: nano gram, SD: 
standard deviation 
* Significant. Chi-square, Fisher exact and Mann Whitney test were used to estimate p value. 
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DISCUSSION 
Recurrent wheezy chest in preschool children 
represent a challenging problem in pediatric 
practice, it has a higher global burden and 
consumes more health-care resources when 
compared with older asthmatic children20. Vitamin 
D deficiency and insufficiency are prevalent in 
Egypt.10,21 This study aimed to assess the serum 25 
(OH) vitamin D level in preschool children aged 2 
to 5 years with recurrent wheezy chest in Assiut, as 
well as, to assess the relationship between serum 25 
(OH) vitamin D level and recurrence, severity, and 
level of asthma control. 
The results showed that 68% of the studied 
patients were males. The high prevalence in males 
is supported by Turkeli et al., 201622 in his study on 
preschool asthmatic children, showing that 60 % of 
them were males, and Abd El-Menem et al., 201310 
found 63% of the studied Egyptian asthmatic 
children were males. This could be explained that 
females have a higher percentage of large airways 
to small ones, with a greater size corrected air flow, 
and more surfactant production that increases 
patency of the small airways. This could reduce the 
risk of wheeze in females23. 
Our study showed that 32% of the studied 
preschool recurrent wheezy children had deficient 
serum 25 (OH) vitamin D level and 21% had 
insufficient level. In consistent with our results 
Turkeli et al., 201622 stated that 25 (OH) vitamin D 
level was deficient in 30.4%, and insufficient in 
30.4% of the studied preschool children, and Jensen 
et al., 201624 stated that approximately three-
quarters of the studied preschoolers were vitamin 
D-insufficient. Also, AbdelKader and Nassar study 
in 201825 found that 29.8% of their studied wheezy 
preschool children had deficient 25 (OH) vitamin D 
levels while 38.4% had insufficient levels. 
Furthermore, Stenberg Hammar et al. 201426 
demonstrated that subnormal levels of 
25(OH)vitamin D are associated with acute wheeze 
in pre-school children. 
Fuleihan 200927 studied 25 (OH) vitamin D 
status in Africa, she reported that its low level could 
be due to limited outdoor activity with inadequate 
sunlight exposure for cultural reasons, insufficient 
vitamin D supplementation during pregnancy and 
lactation, lack of fortification of food with vitamin 
D, and increased burden of infectious disease 
whereby utilization and turnover of vitamin D is 
increased. Also, Turkeli et al., 201622 stated that 
prolonged stay of the preschool children with 
recurrent wheezy chest at home for their protection 
from infections triggering wheeze leads to less 
sunlight exposure, which could be another 
important reason for their low 25(OH) vitamin D 
level. 
On the other hand, Beigelman et al., 201428 
found that 7% of the studied preschool aged 
children were vitamin D deficient, and Dogru et al., 
study 201429 showed that there was no difference in 
25(OH) vitamin D level between asthmatic children 
and healthy control in Turkey. A similar 
observation was reported from the United States, 
where no association was found between vitamin D 
level and wheezy episodes in asthmatic children, 
although asthma was more severe in those with 
vitamin D insufficiency30.  
The previous studies determining the 
relationship between vitamin D level and childhood 
asthma had shown controversial results. This could 
be explained by the difference in sample size, age 
groups, and seasons during which the studies were 
performed. Studies conducted in winter usually had 
lower vitamin D level in comparison with those 
conducted in summer, as solar radiation is weaker, 
and hours of sunlight are shorter in winter 
compared with summer31. 
When comparing our patients according to the 
PRAM score, the total leukocytic count was 
significantly higher in the mild PRAM score group 
in comparison to either moderate or severe PRAM 
score groups. This may signify that the wheezy 
episodes in the mild score group could be 
precipitated by infections that raised the total 
leukocytic count. Although statistically 
insignificant, markers of atopy (absolute eosinophil 
count and serum total IgE) were observed to be 
higher in the moderate and severe PRAM score 
groups versus the mild score group. This agrees 
with Nagavi et al., 200732, and Wever-Hess et al., 
200033 who reported that total IgE levels were 
inversely correlated with asthma severity. Ulrik 
199534 showed a positive correlation between blood 
eosinophil count and the intensity of asthma 
symptoms.  
Our study demonstrated a relationship between 
the deficiency of  25 (OH) vitamin D and the 
severity of the wheezing episodes. This came in 
agreement with Abd El-Menem et al., 201310, 
Brehm et al., 200935 and Sandhu and Casale 201036, 
who all reported that asthmatic children with low 
25(OH) vitamin D level, have a greater risk of 
suffering from severe asthma episodes than those 
with higher vitamin D level. Vitamin D has been 
shown to alleviate respiratory diseases as recurrent 
wheezy chest, as it helps suppressing the 
inflammation, has an anti-inflammatory effect, and 
modulates the bronchomotor tone37.  This could 
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explain why patients with below-sufficient 25(OH) 
vitamin D level have severe wheezy episodes. 
Turkeli et al., study in 201622 showed that the 
number of wheezy episodes in preschool children 
within the previous year was higher in the vitamin 
D deficient and insufficient groups as compared to 
the sufficient group. Dogru et al., study 201429, 
Gupta et al., study38 2011, Brehm et al., study 
201239, and El-Asheer et al., study 201621 showed 
highly significant negative correlation between 
25(OH)vitamin D level and the number of wheezy 
episodes indicating that vitamin D deficiency has a 
significant role in the recurrence of wheezy chest. 
In our study, there was no statistically significant 
difference between the patients with below-
sufficient vitamin D level and sufficient patients as 
regard the number of the wheezy episodes in the 
year preceding the study (p= 0.300), this could be 
explained  by the small sample size included in this 
study. Similar to our study, Alysian et al., 201140 
stated that there was no association between 
25(OH) vitamin D level and the number of wheezy 
episodes in the previous year (p > 0.05).  
 Although statistically insignificant, 58.5 % of 
the patients with below-sufficient vitamin D level 
were uncontrolled versus 40% of those with 
sufficient vitamin D level. Similar observation was 
found by Turkeli et al., study 201622. Chinellato et 
al., 201141 and Gupta et al., 201142 documented a 
significant positive correlation between 25(OH) 
vitamin D level and improved level of asthma 
control in children with asthma. On the other side, 
Alyasin et al., study 201140 did not identify any 
relationship between 25(OH) vitamin D level and 
asthma control in children.  
There was an observed difference in total 
leukocytic count between below-sufficient and 
sufficient patients (p= 0.049), it can be explained in 
the light of absence  of a significant difference in 
eosinophil count between the two groups that there 
was a higher incidence of infections in the below-
sufficient groups. Vitamin D insufficiency is 
supposed to be an important risk factor of infection 
and viral respiratory tract infections are less 
common in children supplemented with vitamin D 
than those not supplemented, and that could be due 
to the immunomodulatory effect of vitamin D 
which may lead to an increased resistance to 
infection43. 
In the present study, there was no statistically 
significant difference in the atopy markers as 
eosinophil count and serum total IgE level (p= 
0.714, and 0.425 respectively) between below-
sufficient and sufficient vitamin D level groups. 
These results are consistent with those of Turkeli et 
al., study 201622 and Alysian et al., study 201138, 
they both concluded that there was no relationship 
between 25 (OH) vitamin D level and atopy 
markers in patients with asthma. However, other 
studies reported significant negative correlation 
between vitamin D and total serum IgE levels21,40,44.  
This study has some strengths and limitations. It 
is the first study conducted in Allergy unit, Children 
Hospital, Assiut University, which serves a large 
population of children especially those living in 
rural areas where there is limited access to medical 
care facilities. Most of the previous cross-sectional 
studies about wheezy chest and asthma in children 
have been conducted on school-aged children and 
little is known about this problem in the preschool 
age. However, the sample size is relatively small, 
which decreases the power of the study and does 
not allow for solid conclusions. The use of a 
questionnaire to parents, although it is the only 
validated tool, may not always be accurate due to 
the possible problems in understanding the 
questions, and over or under-evaluation of 
symptoms.  
In conclusion, vitamin D deficiency and 
insufficiency are prevalent in our studied preschool 
recurrent wheezy children in Assiut, and there is an 
inverse relationship between 25(OH) vitamin D 
level and parameters of asthma severity.  
It is recommended that the estimation of the 
serum 25(OH) vitamin D level can be done in the 
routine workup in children with recurrent wheezy 
chest. Larger follow up studies are required to 
elucidate the effect of vitamin D supplementation 
on different parameters of asthma severity, level of 
asthma control, and how it can therapeutically be 
beneficial in patients with recurrent wheezy chest. 
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